Breaking Down Lion Corporation Financial Health: Key Insights for Investors

Lion Corporation's latest results pack telling signals for investors: nine-month net sales of ¥304,945 million (up 1.3% YoY) and a trailing twelve-month revenue of ¥416.73 billion (TTM +2.18%) sit alongside a powerful operating-profit jump of 62.7% to ¥27,829 million, while net income TTM of ¥20.88 billion and a net profit margin near 5.1% contrast with a 30.8% decline in free cash flow growth and free cash flow of ¥13.90 billion; balance-sheet strengths include a debt-to-equity of 0.10, shareholders' equity of ¥295.97 billion and cash reserves of ¥102.2 billion, and valuation metrics-P/E 22.14, P/B 1.56, EV/EBITDA 10.30-sit against a market cap of ¥450.11 billion and analyst 12-month target of ¥1,886.36 (intrinsic fair value estimated at ¥2,270, ~26% upside); regulatory and market risks from Japan's stagnant consumer spending, modest 6.19% operating margin, and execution hurdles in the new Indian subsidiary compete with growth levers such as health-focused product demand, industrial-division stability, and vertically integrated operations-read on to unpack what these figures mean for Lion's investment case.

Lion Corporation (4912.T) - Revenue Analysis

• Net sales for the nine months ending September 30, 2025: ¥304,945 million (up 1.3% YoY).
• Trailing twelve months (TTM) revenue: ¥416,730 million (≈ ¥416.73 billion), up 2.18% YoY.
• Fiscal year 2024 revenue: ¥412,940 million (≈ ¥412.94 billion), up 2.53% YoY.
• Industrial division contribution: supplies niche chemicals for construction and manufacturing, providing revenue stability.
• Geographic diversification: new Indian subsidiary launched; expected minor impact on consolidated results for 2025.
• Macro headwinds: continued challenges from Japan's stagnant consumer market constrain more robust growth.

• Revenue drivers: household products remain core, industrial chemicals add defensive revenue streams, and modest international expansion (India) targets future growth.
• Risks to topline: weak domestic consumption, currency fluctuations, and slow ramp-up of overseas operations.
• Near-term expectation: continued low-single-digit organic growth with incremental contributions from industrial sales and early-stage overseas subsidiaries.

Lion Corporation (4912.T) - Profitability Metrics

• Operating profit (9 months ended Sep 30, 2025): ¥27,829 million - a 62.7% increase year-on-year.
• Net income (TTM): ¥20.88 billion with a net profit margin of 5.2% (trailing twelve months).
• Reported net profit margin (latest period): 5.05%, indicating consistent bottom-line performance.
• Return on equity (ROE): 7.20%, reflecting moderate returns relative to shareholder equity.
• Gross profit margin: ~45%, signaling efficient cost of goods sold management.
• Operating margin: 6.19%, showing effective operational efficiency.

Lion Corporation (4912.T) Debt vs. Equity Structure

• Debt-to-equity ratio: 0.10 - very low financial leverage.
• Total debt: ¥29.31 billion.
• Total liabilities: ¥151.52 billion.
• Shareholders' equity: ¥295.97 billion.
• Equity ratio: 66.2% (¥295.97bn / ¥447.49bn total assets), indicating a solid balance sheet.
• Return on equity (ROE): 7.20% - decent profitability relative to equity.

• Conservative leverage provides flexibility for strategic M&A or dividend growth decisions.
• Low debt burden reduces refinancing and interest-rate risk.
• Healthy equity buffer supports resilience through cyclical downturns.

Lion Corporation (4912.T) - Liquidity and Solvency

Lion Corporation (4912.T) shows solid short-term liquidity and healthy cash generation metrics that support operational needs and strategic optionality.

• Current ratio: 2.00 - adequate short-term liquidity to cover current liabilities.
• Operating cash flow (OCF): ¥36.51 billion - core cash generation from operations.
• Free cash flow (FCF): ¥13.90 billion - cash available after capital expenditures.
• Cash and equivalents: ¥102.2 billion - strong liquidity reserve.
• OCF / Net income: 0.34 - indicates cash generation is 34% of reported net income.
• FCF / Net income: 0.52 - free cash flow converts to 52% of net income.

These metrics collectively indicate a conservative balance sheet with significant cash reserves that provide flexibility for acquisitions, dividend growth, or capital allocation initiatives. Further context on corporate strategy and history can be found here: Lion Corporation: History, Ownership, Mission, How It Works & Makes Money

Lion Corporation (4912.T) - Valuation Analysis

• P/E = 22.14: implies a fair valuation relative to earnings; not deeply cheap but within reasonable range for consumer goods.
• P/B = 1.56: suggests the stock may be trading below replacement/asset value-a potential value indicator for long-term investors.
• EV/EBITDA = 10.30: indicates elevated growth expectations priced into enterprise value versus operating cash profits.
• Market cap vs. TTM revenue: ¥450.11B market cap on ¥416.73B revenue yields a price-to-sales context near 1.08, signaling moderate revenue backing for market value.

• Analyst consensus target of ¥1,886.36 implies ~13.67% upside from current levels, reflecting cautious optimism among sell-side analysts.
• Intrinsic valuation estimating fair value at ¥2,270 (≈26% upside) highlights divergence between model-driven fair value and market/analyst expectations-this gap can guide differing investor strategies (value vs. momentum).

Lion Corporation (4912.T) - Risk Factors

• Stagnant domestic consumer market: Japan's slow consumer spending environment constrains volume and price leverage, limiting top-line growth prospects for Lion.
• Free cash flow contraction: Free cash flow growth declined by 30.8% on a trailing twelve months (TTM) basis, reducing internal funding available for investment or returns to shareholders.
• Cash-generation efficiency concerns: The operating cash flow to net income ratio is 0.34, indicating only 34% of reported net income has translated into operating cash flow over the measured period.
• Moderate FCF conversion: The free cash flow to net income ratio sits at 0.52, suggesting roughly half of net income converts to free cash flow-reasonable but necessitating monitoring given the recent FCF decline.
• International expansion risk: The company's push into India introduces execution risk, market-entry uncertainty, and potential margin pressure during scale-up.
• Conservative leverage constraints: A conservative balance-sheet posture (limited leverage capacity) can reduce financial flexibility and slow the ability to seize large inorganic or capex-driven growth opportunities.

Lion Corporation (4912.T) Growth Opportunities

• India entry: a wholly owned subsidiary established in India (2024) to access a growing middle-income population-India's middle class estimated at ~300 million and rising consumer health awareness.
• Near-term impact: management expects the Indian subsidiary to have a minor impact on consolidated results for FY2025 while laying groundwork for future scale.
• Health and aging demographics: Japan's 65+ population is ~29% (2023), supporting demand for health-centric oral care, personal care, and home hygiene products where Lion is focused.
• Industrial division stability: niche chemicals and formulation supply to construction and manufacturing provide recurring B2B revenue that cushions consumer cyclicality.
• Vertical integration: Lion's combined production & distribution network improves unit economics and supports margin resilience as volumes expand internationally.

• Commercial rollout: Initial product sets and local manufacturing partnerships aimed at establishing distribution with limited consolidated revenue contribution in FY2025, with scale expected over 3-5 years.
• Product strategy: Prioritizing health-centric oral care, functional toothpaste/toothbrushes, and home hygiene aligned with aging and preventive-care trends-higher ASP and repeat purchase potential.
• Industrial exposure: Continued supply of specialty chemicals and adhesives to construction and manufacturing sectors to sustain baseline revenue during consumer slowdowns.
• Margin expansion: Efficiency gains from vertical integration (in-house formulation, regional production hubs, owned distribution) expected to support operating margin recovery if volumes rise in international markets.